Utilizing a Full 1H NMR Spectrum-Based Metabolomics-AI Approach for Early Diagnosis of Pancreatic Adenocarcinoma
Utilizing a Full 1H NMR Spectrum-Based Metabolomics-AI Approach for Early Diagnosis of Pancreatic Adenocarcinoma
Docket Number
28A-1130315
Abstract
This technology pioneers a novel approach to early detection of pancreatic ductal adenocarcinoma (PDAC) by utilizing advanced 1H full NMR spectral metabolite analysis of small metabolites/lipoproteins in serum. It incorporates key clinical data or serum protein markers and is coupled with multimodal machine learning algorithms to develop a rapid and precise diagnostic tool.
Technological Advantages
- Using a large number of samples from high-risk populations as control groups to ensure the biological significance of the technological development.
- Our methodology conducts comprehensive 1H full-spectral metabolite analysis of serum small metabolites/lipoproteins using 600MHz NMR spectroscopy with SAMPLEJET, incorporating an external control (TSP) and a calibration sample module to enhance the stability of data output.
- Rapidly transform full metabolic spectra into machine learning inputs, effectively solve the imbalance problem of merging various types of data.
- Develop algorithms that accurately predict pancreatic cancer by integrating metabolic data with clinical information and serum protein markers.
- The entire process from serum sample to disease interpretation takes only 20 minutes.
- Combine another algorithms that leverage small molecule profiles to distinguish between pancreatic and colorectal cancer patients.
Applications of Technology
- Early detection of pancreatic cancer
- It can distinguish between different types of cancer with high specificity and assist in diagnosis
- It can be applied to a wide range of metabolic-related diseases domestically and internationally
- This platform also holds potential for diagnostic assessments in drug therapy
Inventor
Chun-Mei Hu, Chao-Ping Hsu, Yu-Ting Chang
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Utilizing a Full 1H NMR Spectrum-Based Metabolomics-AI Approach for Early Diagnosis of Pancreatic Adenocarcinoma